Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint about a Nicorette online ad: use of an infant image and a β43% more effectiveβ claim without…
GSK challenged an AstraZeneca Symbicort SMART leavepiece for an unqualified βRxβ¦ plus as neededβ dosing line. The Panel…
A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate…
PMCPA case AUTH/2613/6/13 about a Cerazette discount scheme. The matter was found to be outwith the scope of…
GSK disclosed that Avandamet ads ran for ~3 months with outdated prescribing information omitting macular oedema as a…
A hospital doctor said an Imraldi mailing requiring a signature was harassment and an inappropriate marketing practice. Panel…
A senior employeeβs LinkedIn comment praising Strivit D3 (βlicensed, prescribed, kosher and halalβ) was ruled to be public…
Complaint said an Ozempic promotional email implied use in all type 2 diabetes patients because βadultsβ appeared later…
Tevaβs HCP and education websites were ruled promotional in parts. Breaches included missing prominent PI/AE signposting online, missing…
Bayer challenged Janssenβs Erleada promotional video alleging off-licence promotion and misleading/disparaging cross-trial safety comparisons. The PMCPA Panel ruled…
One real case. One key lesson. Every week β free.